A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

(EBC) patients receiving Kisqali in 1-year post-treatment analysis 1 Tolerability remained consistent, with fewer treatment discontinuations due to adverse events among pre-menopausal patients 1 ...

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...

Radiologists interpret more than 40 million mammograms in the United States every year. In 2025, AI tools to help detect or ...

The global market for digital breast tomosynthesis (DBT) equipment is forecasted to attain USD 3,267.6 million by 2025, ...

Researchers at the University of Turku, Finland, have developed a new fluorescent probe to visualize signaling dynamics in ...

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

The global Breast Biopsy Devices Market, valued at US$2,255.0 million in 2024, is forecasted to grow at a robust CAGR of 6.5% ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced multiple presentations at ...